TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in this scenario has been assessed only by small fairly studies. However, the information available is quite promising.  

TAVI en bicúspides

TAVR in women generally presents more complications than in men, but severe bicuspid aortic valve stenosis receiving TAVR has not been well looked at. 

This study included 510 patients from one singe center. 225 women (44.1%) and 285 men.

The valve most used was Venus-A Valve (Venus Medtech).

Mean age was 72; men presented more comorbidities, such as kidney failure, COPD and prior heart disease and PCI, in addition to lower left ventricular ejection fraction and more aortic failure associated to stenosis. 

On the other hand, women presented higher aortic velocity and less ascending aortic dilation. 

STS was similar: 5.6±3.8% for women and 4.9±4.2 for men (P=0.066).

Read also: Aspiration Thrombectomy in Acute Coronary Syndrome: Is the Japanese Perspective a Strategy to Emulate?

CT showed type 0 BAV was the most frequent in women and Type I in men. The latter presented more calcification, with larger aortic annuli, valve area and aortic root size. 

During the procedure, the need for a second valve was greater in men. However, there were more vascular complications in women.  

At hospital level, there were no differences in mortality or stroke, neither in need for pacemaker implantation (women 17.1% vs. 22.5% p=0.1).

Read also: Balloon expandable vs Self-Expanding Valves: The Best Option for ViV-TAVR in Small Annuli.

At 30 days and one year, there were no differences in mortality.

Eco-Doppler were analyzed at 30 days and one year. Women presented higher gradient but fewer major to mild paravalvular leaks without reaching statistical value. Both groups improved ejection fraction and presented reduced ventricular mass.

At multivariable analysis, bleeding was a mortality predictor in women while creatinine level and aortic root diameter >45 mm were predictors in men.

Conclusion

In patients with bicuspid aortic valves receiving TAVR, women presented fewer comorbidities, while men more often presented type I BAV, more calcification and larger aortic roots. At hospital level, men presented better evolution, fewer complications but more need of a second valve. Survival at one year was similar between sexes. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Sex Difference in Outcomes Following Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis.

Reference: Jing-Jing He, et al. J Am Coll Cardiol Intv 2022;15:1652–1660.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion....